Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
(Meropenem + vaborbactam) by Melinta Therapeutics for Bacterial Infections: Likelihood of Approval
(Meropenem + vaborbactam) is under clinical development by Melinta Therapeutics and currently in Phase I for Bacterial Infections. According to...